rxstat › Classes › Ace Inhibitors, Combinations
Ace Inhibitors, Combinations: shortage status in Canada
5 of the 7 ace inhibitors, combinations rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Hydrochlorothiazide Lisinopril (Zestoretic) Partial shortage 3 of 16 reported products affected
Hydrochlorothiazide Quinapril (Accuretic) Partial shortage 4 of 10 reported products affected · est. return Aug 14, 2026
Hydrochlorothiazide Ramipril (Altace Hct) Partial shortage 1 of 22 reported products affected
Indapamide Perindopril Erbumine (Coversyl Plus Ld) Partial shortage 2 of 11 reported products affected
Perindopril Arginine Amlodipine (Viacoram) Partial shortage 2 of 6 reported products affected
Hydrochlorothiazide Cilazapril (Inhibace Plus) No current shortage
Verapamil Trandolapril (Tarka) Discontinued 0 of 2 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.